Archived article
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
AJ Bell is an easy to use, award-winning platform Open an account
We've accounts to suit every investing need, and free guides and special offers to help you get the most from them.
You can get a few handy suggestions, or even get our experts to do the hard work for you – by picking one of our simple investment ideas.
All the resources you need to choose your shares, from market data to the latest investment news and analysis.
Funds offer an easier way to build your portfolio – we’ve got everything you need to choose the right one.
Starting to save for a pension, approaching retirement, or after an explainer on pension jargon? We can help.
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
Nick Train of asset manager Lindsell Train has joined other big name investors Fundsmith and Majedie Asset Management to buy shares in Fevertree (FEVR:AIM) following recent share price weakness.
The fund manager has taken a maiden stake in the posh tonics business for his £1.7bn Finsbury Growth and Income Trust (FGT), calling it a ‘classic Lindsell Train idea’ thanks to strong brand power and global reach.
Train told investors at the annual Finsbury shareholder meeting that he had been waiting a long time for an opportunity to buy, ‘having kicked ourselves for not buying it seven years ago’.
Fevertree has seen its share price collapse by nearly two thirds over the past nine months after seeing growth slow, leading to profit warnings in November 2019 and January 2020. The stock currently trades at £12.85.
Fundsmith’s Smithson Investment Trust (SSON) added to its Fevertree stake in January this year having first invested last summer, flagging the firm’s strong market position, growth potential and ‘impressive’ returns on capital.
Majedie Asset Management, which runs investment trust Majedie Investments (MAJE), took its Fevertree stake to more than 5% of the company on 24 February.
DISCLAIMER: Editor Daniel Coatsworth owns shares in Smithson
These articles are provided by Shares magazine which is published by AJ Bell Media, a part of AJ Bell. Shares is not written by AJ Bell.
Shares is provided for your general information and use and is not a personal recommendation to invest. It is not intended to be relied upon by you in making or not making any investment decisions. The investments referred to in these articles will not be suitable for all investors. If in doubt please seek appropriate independent financial advice.
Investors acting on the information in these articles do so at their own risk and AJ Bell Media and its staff do not accept liability for losses suffered by investors as a result of their investment decisions.
The value of your investments can go down as well as up and you may get back less than you originally invested. We don't offer advice, so it's important you understand the risks, if you're unsure please consult a suitably qualified financial adviser. Tax treatment depends on your individual circumstances and rules may change. Past performance is not a guide to future performance and some investments need to be held for the long term.